Clinical Trials Sponsored by CareerPoint Marin

Total 1415 results

Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Prevent Hospitalization for COVID-19 Patients (COVER2)

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Completed

COVID-19 Impact on the Lombardy Region's Emergency System

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Remission Clinic in Proteinuric Chronic Nephropathies

Chronic Kidney Disease

Italy
Robert C. Martin
University of Louisville

Completed

Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin (DELTIC)

Unresectable Intrahepatic Cholangiocarcinoma

United States
University of Pennsylvania
Amarin Pharma Inc.

Completed

Vascepa to Accelerate Lipoprotein Uptake and Elimination (VALUE)

Dyslipidemias | Lipid Disorder | Triglycerides High

United States
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Treat COVID-19 Patients at Home. (COVER)

COVID 19

Italy
Mario Negri Institute for Pharmacological Research

Completed

Decision-aid on Breast Cancer Screening

Breast Cancer

Italy
Karin Schindler

Completed

Infant Nutrition in Austria (Sukie)

Breast Feeding

Austria
Mario Negri Institute for Pharmacological Research

Terminated

Insulin Treatment in Diabetic Older People With Heart Failure. (Insulin-HF)

Heart Failure | Diabetes Mellitus, Type 2

Italy
Mario Negri Institute for Pharmacological Research

Completed

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma (Ortataxel)

Glioblastoma

Italy
IRCCS Fondazione Stella Maris
BioRobotics Institute

Completed

AOT and ICT for Hemiplegia (Tele-UPCAT)

Hemiplegia | Hemiplegic Cerebral Palsy

Italy
Martin Gutierrez
Novartis

Withdrawn

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Prostate Cancer

United States
Peking University
Marino Biotechnology Co., Ltd.

Unknown

Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma

B-cell Lymphoma

China
Mario Negri Institute for Pharmacological Research

Completed

E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF (SIM-AF)

Atrial Fibrillation | Elderly | Geriatrics | Simulation Training | Anticoagulant Drugs | Internal Medicine | Drug Prescriptions

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) (ORCHIDEE)

Renal Cell Carcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

Autosomal Dominant Polycystic Kidney Disease

Italy
Peking University
Marino Biotechnology Co., Ltd.

Unknown

Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma

Relapsed or Refractory B-cell Lymphoma

China
Marie-Pierre TAVOLACCI

Unknown

Binge Drinking And Addiction : Case-Control Study in Hospital (BACH)

Alcohol Dependence

France
Maria J.G.T. Vehreschild

Terminated

Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E (CLEAR)

Cancer

Germany
Martin Angst
SRI International

Completed

Heritability of Opioid Effects: A Twin Study

Pain

United States
Maria Stoenoiu

Unknown

Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis (TOVERA)

Rheumatoid Arthritis

Belgium
Ibis Reproductive Health
Marie Stopes International

Unknown

Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

Medical Abortion

Mexico
Mario Negri Institute for Pharmacological Research

Completed

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain (RER)

Neuropathic Pain | Tumor | Cancer Pain | Breakthrough Cancer Pain

Italy
Malin Jonsson Fagerlund

Completed

Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea

OSA | Neuromuscular Blockade | Rocuronium | Hypoxic Ventilatory Response | CPAP

Sweden
Mario Negri Institute for Pharmacological Research

Completed

RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. (CERP)

Cancer | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Completed

Multicentric Observational Study on Quality of Life in Glaucoma

Primary Open-angle Glaucoma

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Type 2 Diabetes | Early Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Completed

Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma (GILDA)

Colorectal Cancer | Surveillance
Consorzio Mario Negri Sud
Artsana SpA

Completed

Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. (AGO01)

Type 1 Diabetes | Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

Telmisartan Versus Losartan in Kidney Transplantation (COSTANT)

Renal Transplant

Italy
St Marina University Hospital, Varna, Bulgaria

Completed

Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors

Helicobacter Pylori Infection

Bulgaria
St Marina University Hospital, Varna, Bulgaria

Completed

Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children (AADreuter)

Gastroenteritis | Clostridium Difficile Infection | Antibiotic Associated Diarrhea

Bulgaria
Mario Negri Institute for Pharmacological Research

Completed

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

Cardiovascular Diseases

Italy
Mario Negri Institute for Pharmacological Research

Completed

Acetylcarnitine and Insulin Sensitivity

Type 2 Diabetes Mellitus

Italy
Amarin Neuroscience Ltd
Huntington Study Group

Completed

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Huntington Disease

United States, Canada
Mario Negri Institute for Pharmacological Research

Completed

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Kidney Transplant

Italy
Carina Mari Aparici

Withdrawn

68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)

Fever of Unknown Origin

United States
Albert DeNittis

Unknown

Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer

Prostate Neoplasms

United States
Mario Negri Institute for Pharmacological Research

Not yet recruiting

1 vs 7 RATG Infusions in Renal Transplantation (ONSET)

Kidney Replacement

Italy
Dr. Karin Hediger

Not yet recruiting

Dog Presence and Oxytocin on Trust Towards Therapists (DOT)

Depressive Symptoms | Human-Animal Interaction
Mario Negri Institute for Pharmacological Research

Not yet recruiting

An Outcome Analysis of Primary Membranous Nephropathy (PROMENADE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

New Analytic Tools for aHUS and C3G Diagnosis (COMPRare)

Healthy | Hemolytic-Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
KLS Martin
Clinical Study Centers, LLC

Recruiting

Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments.

Arthrosis | Pseudarthrosis | Intraarticular Fracture | Extraarticular Fracture

Germany
Maria I. Lapid, M.D.

Recruiting

iTBS rTMS in Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Mario Widmer

Recruiting

Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT (Ekso-FES)

Spinal Cord Injuries | Gait Disorders, Neurologic

Switzerland
Mario Negri Institute for Pharmacological Research

Recruiting

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Brain Injuries, Acute

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (ATRA)

Breast Neoplasm Female

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Autoreactive B Cells in Membranous Nephropathy (PEPTIDE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. (CHECK)

Colorectal Neoplasms

Italy
Martin Huelsmann

Recruiting

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Heart Diseases | Diabetes Mellitus, Type 2

New Zealand, Austria, Netherlands, Spain, United Kingdom

Clinical Trials Sponsored by CareerPoint Marin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations